From Malignant Hypertension to 6.7% Body Fat: One Mans GLP-1 Journey @thee_rmz
From Malignant Hypertension to 6.7% Body Fat: One Mans GLP-1 Journey  @thee_rmz
Uploaded July 2026 | Updated November 2026, 3 days ago
What happens when you do everything right — exercise, diet, lifestyle — and your body still works against you?

In this episode of Healthy MENtality, I sit down with Barrington, a 55-year-old educator, historian, and African American man of Jamaican descent whose health journey spans more than two decades of serious cardiovascular challenge — and a transformation that is rewriting what's possible in midlife.

Barrington's story isn't a simple weight-loss story. At his worst, his blood pressure was recorded at 250/150 — a level classified as malignant hypertension and associated with stroke, kidney damage, and heart disease. He carried a chronic kidney disease diagnosis for years. He developed central serous retinopathy linked to elevated cortisol and stress. And he carries a markedly elevated lipoprotein(a) of 445 nmol/L — an inherited cardiovascular risk factor most people have never even heard of.

Despite consistent exercise and a disciplined lifestyle, Barrington found himself in his early 50s fighting increasing metabolic resistance, rising visceral fat, and diminishing returns.

In September 2025, he began compounded tirzepatide therapy — not as a cosmetic weight-loss drug, but as what he calls a disease-modifying therapy to address long-term cardiometabolic risk.
The results have been remarkable:

✅ ~30 lbs lost (173 lbs → 143–145 lbs)

✅ Body fat: 14.7% → 6.7%

✅ Visceral fat reduced to essentially zero on DEXA scan

✅ Blood pressure consistently 110/70

✅ Treadmill stress test: 15.4 METs, no ischemia

✅ After 20+ years on metoprolol, his cardiologist is now tapering him off

In this conversation, we go deep on the emotional and psychological cost of living under long-term health uncertainty, what it means to be a gay Black man navigating the healthcare system, the stigma men face around GLP-1 medications, and why Barrington believes cardiometabolic disease must be actively managed — not simply observed.

This episode is for every man who has been told his numbers are "fine" while his body tells a different story.

Subscribe for honest, evidence-based conversations about men's health — body, mind, and everything in between.

=======================================================

GLP-1 Meet Up

onceuponameetup.com

=======================================================

Affiliate Links (I earn commission for qualifying purchases)

Gruns: grns.sjv.io/AgoLV7

========================================================

FOLLOW ME
TikTok: tiktok.com/@thee_rmz
Instagram: instagram.com/thee_rmz

========================================================

DISCLAIMER: No information provided here is to be construed as medical advice. Always consult with a licensed medical provider for medical advice.


#glp1 #zepbound #mounjaro #weightloss #weightlossjourney #glp #tirzepatide #semaglutide #wegovy #ozempic #menshealth #beforeandafter #beforeandafterweightloss
From Malignant Hypertension to 6.7% Body Fat: One Mans GLP-1 Journey3:30am Gym Days. Momentum Continues 💪🏽GLP-1 Meet-Up: RMZ & Paul On Wheels Meet IRL! #glp1Ozempic for $150? Inside the Week’s Biggest GLP-1 HeadlinesThe Weekly Shot: GLP-1s — Lilly Trial Halt, Oral Drug Launch, Genetic Insights & Psoriasis BenefitsHealthy MENtality Live: Men’s Health Without the BSTRT Changed Everything — Heres What They Dont SayMy 4-Month Gym Break Is Over | Week 2 UpdateCoughing Up Blood Led to 127 lbs Lost on Zepbound118 lbs Down: My 2-Year GLP-1 Before & After TransformationSet a Goal & Couldnt Stop #GymReset #FitnessMotivation #ShortsDo You Have to Take Ozempic or Zepbound Forever? New Study Has Answers
RMZ |

From Malignant Hypertension to 6.7% Body Fat: One Man's GLP-1 Journey

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER